Sunshine Lake Pharma Co., Ltd.

Haoxiong Qin

Weihua Wang

Zheng Gu

Jianhao Li

Yingjun Zhang

Jianyu Liu

Zheng Li

Xuli Wang

Xinshan Deng

An isoquinolinone compound acts as an inhibitor of semicarbazide-sensitive oxidase (SSAO) and/or vascular adhesion protein-1 (VAP-1), and the use thereof, and further relates to a pharmaceutical composition containing the compound. The compound or the pharmaceutical composition can be used to prepare a drug for preventing, treating or ameliorating inflammation and/or inflammation-related diseases, diabetes and/or diabetes-related diseases in patients, and especially can be used to prepare a drug for preventing, treating or ameliorating non-alcoholic fatty liver diseases in patients.

Isoquinolinone compound for inhibiting ssao/vap-1, and use thereof

An amine compound serving as a semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein-1 (VAP-1) inhibitor, a pharmaceutical composition, and an application thereof in medicines that can be used for treating inflammation and/or inflammation related diseases, diabetes and/or a disease related diabetes, psychiatric disorder, ischemic disease, vascular disease, fibrosis, or tissue transplant rejection.

Amine compound for inhibiting SSAO/VAP-1 and use thereof

Growing community of inventors

Dongguan, China

Haoxiong Qin